Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection
Biswa Mohan Sahoo, B. V. V. Ravi Kumar, J. Sruti, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing
Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Repurposing of Drug Aspirin in Colon Cancer: Therapeutic Approach
Vrushali Neve, Abhijeet Kamble, Pawan Karwa
Clinical Cancer Investigation Journal (2024) Vol. 13, Iss. 1, pp. 23-28
Open Access | Times Cited: 3
A Review: Antimicrobial Therapy for Human Pythiosis
Sadeep Medhasi, Ariya Chindamporn, Navaporn Worasilchai
Antibiotics (2022) Vol. 11, Iss. 4, pp. 450-450
Open Access | Times Cited: 16
Experimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review
Shin Jie Yong, Alice Halim, Michael Halim, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 7, pp. 655-667
Closed Access | Times Cited: 9
In silico drug repurposing in COVID-19: A network-based analysis
Pasquale Sibilio, Simone Bini, Giulia Fiscon, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111954-111954
Open Access | Times Cited: 20
Identification of Repurposed FDA Drugs by Targeting Sclerostin via the Wnt Pathway for Alveolar Bone Formation
Pradeep Kumar Yadalam, Raghavendra Vamsi Anegundi, Ramya Ramadoss, et al.
European Journal of General Dentistry (2024) Vol. 13, Iss. 02, pp. 125-133
Open Access | Times Cited: 2
Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases
Neetu Rani, Aastha Kaushik, Shefali Kardam, et al.
Progress in molecular biology and translational science (2024), pp. 23-70
Closed Access | Times Cited: 2
Use of Drug Sensitisers to Improve Therapeutic Index in Cancer
Yushan Chen, Enhui Jin, Philip J. Day
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 928-928
Open Access | Times Cited: 2
Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
Sanoj Rejinold N, Goeun Choi, Huiyan Piao, et al.
Materials (2021) Vol. 14, Iss. 14, pp. 3792-3792
Open Access | Times Cited: 19
Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells
Ahmad Besaratinia, Andrew W. Caliri, Stella Tommasi
DNA repair (2021) Vol. 106, pp. 103180-103180
Open Access | Times Cited: 18
Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis
Chih‐Hao Chen, K.C. Hung, Chii-Yuan Huang, et al.
Journal of the Chinese Medical Association (2023) Vol. 86, Iss. 3, pp. 274-281
Open Access | Times Cited: 7
Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections
Bandhan Sarker, Md. Matiur Rahaman, Md. Ariful Islam, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281981-e0281981
Open Access | Times Cited: 7
Rutin Potentially Binds the Gamma Secretase Catalytic Site, Down Regulates the Notch Signaling Pathway and Reduces Sphere Formation in Colonospheres
Atul Kumar Singh, Mohd Shuaib, Kumari Sunita Prajapati, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 926-926
Open Access | Times Cited: 11
Synthesis and antimicrobial testing of 5‐fluorouracil derivatives
Mrunal U. Patil, Serhii Krykun, Frédéric Garzino, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Open Access | Times Cited: 6
In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K
Vinothini Boopathi, Jinnatun Nahar, Mohanapriya Murugesan, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19341-e19341
Open Access | Times Cited: 6
Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2
Prakash Jha, Daman Saluja, Madhu Chopra
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-11
Open Access | Times Cited: 10
Alkenyl Thioetherification Enabled by Nickel Catalysis
Bing Xu, Huan Xiang, Yuqiong Tan, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 7, pp. 4592-4605
Closed Access | Times Cited: 5
Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site
Andrey Bogoyavlenskiy, Madina Alexyuk, Pavel Alexyuk, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3766-3766
Open Access | Times Cited: 5
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 5
Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment
Mathew Timothy Artuz Manuel, Lemmuel L. Tayo
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1564-1564
Open Access | Times Cited: 5
The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses
Оlga I. Yarovaya, Aleksandr S. Filimonov, Dmitry S. Baev, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 215-215
Open Access | Times Cited: 1
Cytotoxicity of ZIF-8@APTES-MS on murine melanoma cells
Seyedeh Narges Mousavi Kani, Abdolraouf Samadi‐Maybodi, Hossein Najafzadehvarzi
Journal of Materials Science (2024) Vol. 59, Iss. 9, pp. 3959-3969
Closed Access | Times Cited: 1
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 602-609
Closed Access | Times Cited: 1
PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY
Jackson A. Pereira, Eduardo Damasceno Costa
INDIAN DRUGS (2024) Vol. 61, Iss. 02, pp. 23-34
Closed Access | Times Cited: 1
Synergizing drug repurposing and target identification for neurodegenerative diseases
Mehar Sahu, Shrutikirti Vashishth, Neha Kukreti, et al.
Progress in molecular biology and translational science (2024), pp. 111-169
Closed Access | Times Cited: 1

Scroll to top